Clinical & Scientific Intelligence
Landscape, evidence appraisal and asset / target analysis.
- Clinical landscape
- Evidence appraisal
- Asset / target analysis
TrialSign Clinical Intelligence
TrialSign turns fragmented clinical, scientific, regulatory and patent evidence into decision-ready intelligence.
The problem
Evidence is fragmented across registries, papers, regulatory sources, patents and competitive programs. TrialSign connects it.
Structured evidence. Human-reviewed interpretation.
What we do
Landscape, evidence appraisal and asset / target analysis.
Patent families, prior art and claim-level evidence mapping.
Competitive context, evidence gaps and decision support.
How it works
Proprietary intelligence workflows support evidence discovery, normalization and quality control.
We define the decision.
We search trials, literature, regulatory and patents.
Evidence is source-linked and analyst-reviewed.
You receive decision-ready intelligence.
Deliverables
Executive Decision Book. For leadership, investment and BD decisions.
Scientific Evidence Dossier. For deep scientific and technical review.
Private Intelligence Room. For source-linked evidence exploration when scoped.
Public demonstration

Engagement frame, version, data cutoff and scope signal.

Leadership-level indicators and gating items.

Short findings separated from source notes and limitations.
Expertise
TrialSign combines biomedical research expertise with structured clinical, scientific and IP intelligence.
Start with the question
Tell us the question. We define the evidence plan.